Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Journals
  3. European Psychiatry
  4. Volume 13
Journal Home
Refine listing

Refine listing

Access:
Publication date:

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

Volume 13 - 1998

Contents

Page 37 of 41

Wed-P38

Symposia

  • The drug precription in schizophrenia pathology in France

  • B. Lachaux, G. Ardiet, D. Adouard
  • Published online by Cambridge University Press:
    16 April 2020, p. 299s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P99

Symposia

  • Immunologic disturbances in irradiation exposed individuals

  • I. Domachneva, V. Krasnov, O. Atamanova, M. Yurkin
  • Published online by Cambridge University Press:
    16 April 2020, pp. 316s-317s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P39

Symposia

  • Membrane phospholipid abnormalities as a biochemical basis for the neurodevelopmental concept of schizophrenia

  • D.F. Horrobin
  • Published online by Cambridge University Press:
    16 April 2020, p. 299s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P40

Symposia

  • P50 in deficit and non deficit schizophrenia

  • S. Louchart, F. Thibaut, D. Levillain, A. van Der Elst, S. Dollfus, M. Petit
  • Published online by Cambridge University Press:
    16 April 2020, p. 300s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P41

Symposia

Wed-P42

Symposia

  • Influence of severity and duration of psychotic state on the level of middle molecules

  • E. Misionzhnik, A. Molodetskikh, S. Mosolov, M. Uzbekov
  • Published online by Cambridge University Press:
    16 April 2020, p. 300s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P43

Symposia

Wed-P44

Symposia

Wed-P45

Symposia

Wed-P46

Symposia

  • Pharmacotherapy of anxiety in schizophrenia

  • M. Munjiza, D. Lapčević, N. Ljubomirović, M. Veličković
  • Published online by Cambridge University Press:
    16 April 2020, pp. 301s-302s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P47

Symposia

Wed-P48

Symposia

Wed-P49

Symposia

  • Ziprasidone: In vivo evidence of central 5HT1A agonist activity

  • H. Rollema, J.S. Sprouse, Y. Lu, L.S. Reynolds, J.P. Braselton, S.H. Zorn
  • Published online by Cambridge University Press:
    16 April 2020, p. 302s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P50

Symposia

  • Intramuscular (IM) ziprasidone vs. IM haloperidol in patients with acute, non-organic psychosis

  • S. Brook, M. Krams, K. Gunn
  • Published online by Cambridge University Press:
    16 April 2020, p. 303s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P51

Symposia

Wed-P52

Symposia

Wed-P53

Symposia

  • Intramuscular ziprasidone 10 mg and 20 mg in patients with psychosis and acute agitation

  • K.R Reeves, R.H. Swift, E.P. Harrigan
  • Published online by Cambridge University Press:
    16 April 2020, p. 304s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P54

Symposia

  • A comparison of intramuscular (IM) ziprasidone with IM haloperidol

  • R.H. Swift, E.P. Harrigan, D.P. van Kammen
  • Published online by Cambridge University Press:
    16 April 2020, p. 304s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P55

Symposia

Wed-P56

Symposia

Page 37 of 41